肝硬度值升高与降低均独立与NAFLD患者肝脏相关事件风险相关
本研究基于NASH临床研究网络NAFLD数据库2和3的前瞻性队列,纳入1403例NAFLD患者,平均随访4.4年。肝硬度值进展至≥10 kPa者肝脏相关事件累积发生率高于未进展者(16% vs 4%,校正HR 4.0),而肝硬度值回退至<10 kPa者肝脏相关事件发生率低于未回退者(7% vs 32%,校正HR 0.25)。肝硬度值随时间的变化独立且双向地与肝脏相关事件风险相关。
要点
- 肝硬度值进展至≥10 kPa者肝脏相关事件累积发生率16%,未进展者4%,校正HR 4.0。
- 肝硬度值回退至<10 kPa者肝脏相关事件发生率7%,未回退者32%,校正HR 0.25。
- 肝硬度值变化是NAFLD患者临床结局的无创替代指标。
核心结论
- 肝硬度值随时间的变化独立且双向地与肝脏相关事件风险相关,是NAFLD患者临床结局的无创替代指标。
研究设计与样本
- NASH临床研究网络领导的NAFLD数据库2和3研究的前瞻性队列,纳入1403例参与者,平均随访4.4年。
- 进展至代偿性晚期慢性肝病定义为初始振动控制瞬时弹性成像肝硬度值<10 kPa者达到≥10 kPa;回退定义为基线肝硬度值≥10 kPa者达到<10 kPa。
- 肝脏相关事件定义为肝相关死亡、肝移植、肝细胞癌、MELD>15、发生静脉曲张或肝功能失代偿。
- 采用单变量和多变量区间删失Cox回归分析比较不同肝硬度值进展和回退状态的累积肝脏相关事件概率。
主要发现
- 1403例参与者中,平均随访4.4年期间发生89例肝脏相关事件,肝脏相关事件年发生率为1.5(95% CI 1.2-1.8)。
- 在风险人群中,进展至肝硬度值≥10 kPa或≥15 kPa者分别占29%和17%,回退至肝硬度值<10 kPa或<15 kPa者分别占44%和49%。
- 进展至代偿性晚期慢性肝病(≥10 kPa)者肝脏相关事件累积发生率高于未进展者(16% vs 4%,校正HR 4.0;95% CI 1.8-8.9;p<0.01)。
- 从代偿性晚期慢性肝病回退(至肝硬度值<10 kPa)者肝脏相关事件发生率低于未回退者(7% vs 32%,校正HR 0.25;95% CI 0.10-0.61;p<0.01)。
关键数值与推荐
- 肝硬度值进展至≥10 kPa者肝脏相关事件累积发生率为16%,未进展者为4%,校正HR 4.0(95% CI 1.8-8.9;p<0.01)。
- 肝硬度值回退至<10 kPa者肝脏相关事件发生率为7%,未回退者为32%,校正HR 0.25(95% CI 0.10-0.61;p<0.01)。
- 肝脏相关事件年发生率为1.5(95% CI 1.2-1.8)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The clinical significance of change in liver stiffness measurement (LSM) by vibration-controlled transient elastography (VCTE) in patients with non-alcoholic fatty liver disease (NAFLD) is not well-understood. We prospectively defined rates of progression to and regression from LSM-defined compensated advanced chronic liver disease (cACLD) and their associations with liver-related events (LREs). METHODS: Participants in the NASH Clinical Research Network-led NAFLD Database 2 and 3 studies were included. Progression to cACLD was defined as reaching LSM ≥10 kPa in participants with LSM <10 kPa on initial VCTE; regression from cACLD was defined as reaching LSM <10 kPa in participants with baseline LSM ≥10 kPa. LREs were defined as liver-related death, liver transplant, hepatocellular carcinoma, MELD >15, development of varices, or hepatic decompensation. Univariate and multivariable interval-censored Cox regression analyses were used to compare the cumulative LRE probability by LSM progression and regression status. RESULTS: In 1,403 participants, 89 LREs developed over a mean follow-up of 4.4 years, with an annual incidence rate for LREs of 1.5 (95% CI 1.2-1.8). In participants at risk, progression to LSM ≥10 or ≥15 kPa occurred in 29% and 17%, respectively, whereas regression to LSM <10 or <15 kPa occurred in 44% and 49%, respectively. Progressors to cACLD (≥10 kPa) experienced a higher cumulative LRE rate vs. non-progressors (16% vs. 4%, adjusted hazard ratio 4.0; 95% (1.8-8.9); p <0.01). Regressors from cACLD (to LSM <10 kPa) experienced a lower LRE rate than non-regressors (7% vs. 32%, adjusted hazard ratio 0.25; 95% CI 0.10-0.61; p <0.01). CONCLUSIONS: Change in LSM over time is independently and bi-directionally associated with risk of LRE and is a non-invasive surrogate for clinical outcomes in patients with NAFLD. IMPACT AND IMPLICATIONS: The prognostic value of change in LSM in patients with NAFLD is not well understood. In this large prospective study of patients with NAFLD and serial vibration-controlled transient elastography exams, baseline and dynamic changes in LSM were associated with the risk of developing liver-related events. LSM is a useful non-invasive surrogate of clinical outcomes in patients with NAFLD.
引用
- Gawrieh S, Vilar-Gomez E, Wilson LA, et al. Increases and decreases in liver stiffness measurement are independently associated with the risk of liver-related events in NAFLD. J Hepatol. 2024. PMID: 38762169. doi:10.1016/j.jhep.2024.05.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。